2021
DOI: 10.21037/jtd-21-190
|View full text |Cite
|
Sign up to set email alerts
|

The significance of systematic lymph node dissection in surgery for early-stage non-small cell lung cancer patients aged ≤40 years

Abstract: Background: Surgery remains the best option for treating early-stage non-small cell lung cancer (NSCLC), and lymph node dissection (LND) is an important step in this approach. However, the extent of LND in the general age population, especially in young patients, is controversial. This retrospective study aimed to investigate the correlation between systematic lymph node dissection (SLND) and prognosis in young (≤40 years) patients with stage IA NSCLC. Methods: Clinicopathological data of 191 patients aged ≤40… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 33 publications
0
1
0
Order By: Relevance
“…Preoperative evaluation of mediastinal lymph nodes (LNs) in patients with lung cancer is essential for determining optimal treatment strategies in the management of primary lung cancer. On the one hand, the status of mediastinal LNs metastasis can not only affects the formulation of perioperative diagnosis and treatment strategies (1)(2)(3), but also affects the survival time of patients after surgery (4)(5)(6). Therefore, the current National Comprehensive Cancer Network guidelines for non-small cell lung cancer (NSCLC) suggests that N1 (ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary nodes) and N2 (ipsilateral mediastinal and/or subcarinal lymph node(s)) node resection and mapping should be a routine component of lung cancer resections with a minimum of three N2 stations sampled or complete lymph node dissection (7).…”
Section: Introductionmentioning
confidence: 99%
“…Preoperative evaluation of mediastinal lymph nodes (LNs) in patients with lung cancer is essential for determining optimal treatment strategies in the management of primary lung cancer. On the one hand, the status of mediastinal LNs metastasis can not only affects the formulation of perioperative diagnosis and treatment strategies (1)(2)(3), but also affects the survival time of patients after surgery (4)(5)(6). Therefore, the current National Comprehensive Cancer Network guidelines for non-small cell lung cancer (NSCLC) suggests that N1 (ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary nodes) and N2 (ipsilateral mediastinal and/or subcarinal lymph node(s)) node resection and mapping should be a routine component of lung cancer resections with a minimum of three N2 stations sampled or complete lymph node dissection (7).…”
Section: Introductionmentioning
confidence: 99%